Fu-Sheng Wang

Quick facts

Marketed products

• Placebo & Entecavir · Virology / Hepatology
  Entecavir inhibits hepatitis B virus reverse transcriptase and protein priming, reducing viral replication in chronic hepatitis B infection.

Phase 1 pipeline

• Metformin & Entecavir

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Fu-Sheng Wang portfolio CI brief
• Fu-Sheng Wang pipeline updates RSS